In 41 patients with hyperlipemia, n-3 fatty acids together with simvastatin reduced the free tissue factor pathway inhibitor fraction and inhibited the activation of factor VII occurring [31] even though statin treatment can also reduce VTE risk [32]. The gene discussed is F7; the disease is familial hyperlipidemia.